News

Dr. Moustache and the Bubble Baby Disease: A CIRM Success Story

July 30, 2024

Dr. Moustache has done it again.

Another child has been treated for a deadly affliction known as the “bubble boy” disease. Dr. Moustache and his “magical team” did have a little help, courtesy of the people of California who put tens of millions of dollars into financing his cell and gene therapy.

Read more about Dr. Moustache and the Bubble Baby Disease: A CIRM Success Story

Innovation Magazine Summer 2024 Edition

July 10, 2024

In this issue:
- A new partnership with UCLA Ventures
- Funding updates for TORL, Pelage Pharmaceuticals, UCLA Samueli, and ImmPACT Bio
- A trip to the UCLA Research Park
- Event wrap ups for MedTech, LABEST and UCLA Ventures dinner
and more

Read more about Innovation Magazine Summer 2024 Edition

Biden administration proposal threatens innovative research

April 2, 2024

Biden administration proposal threatens innovative research at universities across the country

UCLA students transition between classes at the Westwood campus on September 27, 2022. (Photo by Dean Musgrove, Los Angeles Daily News/SCNG)

Read more about Biden administration proposal threatens innovative research

UCLA Samueli to Lead $4 Million Cell Research Funded by Mark Zuckerberg

March 1, 2024

Read more about UCLA Samueli to Lead $4 Million Cell Research Funded by Mark Zuckerberg

CrewLAB Raises $1.6M to Democratize Data & Technology for Endurance Sports Teams

March 1, 2024

CrewLAB Raises $1.6M to Democratize Data & Technology for Endurance Sports Teams

Read more about CrewLAB Raises $1.6M to Democratize Data & Technology for Endurance Sports Teams

GV Backs Hair Loss Biotech out of UCLA with PhII set for mid-2024

March 1, 2024

Pelage Pharmaceuticals, a Los Angeles-based hair loss biotech based on research out of UCLA, has reeled in a $16.75 million Series A and plans to start a mid-stage trial later this year.

See full article below;